Institution · Lander Institute
Most cited papers from Lander Institute
What are the most cited papers from Lander Institute?
The most cited paper from Lander Institute is "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (Daniel J. Klionsky et al., 2021), with 2,743 citations. Next come "Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer" (1,786) and "Autophagy in major human diseases" (1,608).
Showing 50 of 60 papers. Every paper with more than 240 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy | 2 Jan 2021 | 2,743 |
| 2 | Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer Himisha Beltran, Davide Prandi, Juan Miguel Mosquera et al. · Nature Medicine | 8 Feb 2016 | 1,786 |
| 3 | Autophagy in major human diseases Daniel J. Klionsky et al. · The EMBO Journal | 30 Aug 2021 | 1,608 |
| 4 | Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors Lorenzo Galluzzi, Juliette F Humeau, Aitziber Buqué et al. · Nature Reviews Clinical Oncology | 5 Aug 2020 | 1,375 |
| 5 | Immunogenic cell stress and death Guido Kroemer, Claudia Galassi, Laurence Zitvogel et al. · Nature Immunology | 10 Feb 2022 | 1,352 |
| 6 | Detection of immunogenic cell death and its relevance for cancer therapy Jitka Palich Fucikova, Oliver Kepp, Lenka Kašíková et al. · Cell Death and Disease | 26 Nov 2020 | 1,162 |
| 7 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death Lorenzo Galluzzi et al. · Journal for ImmunoTherapy of Cancer | Mar 2020 | 1,116 |
| 8 | SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer Ping Mu et al. · Science | 5 Jan 2017 | 1,089 |
| 9 | Mitochondrial control of inflammation Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait et al. · Nature reviews. Immunology | 25 Jul 2022 | 1,042 |
| 10 | Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine Chantal Pauli et al. · Cancer Discovery | 22 Mar 2017 | 969 |
| 11 | Intratumoral heterogeneity in cancer progression and response to immunotherapy Ilio Vitale, Efrat Shema, Sherene Loi et al. · Nature Medicine | Feb 2021 | 874 |
| 12 | Artificial Intelligence in Cancer Research and Precision Medicine Bhavneet Bhinder, Coryandar M. Gilvary, Neel S. Madhukar et al. · Cancer Discovery | Apr 2021 | 794 |
| 13 | A molecular single-cell lung atlas of lethal COVID-19 Johannes C. Melms et al. · Nature | 29 Apr 2021 | 750 |
| 14 | Somatic mutations precede acute myeloid leukemia years before diagnosis Pinkal M. Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov et al. · Nature Medicine | Jul 2018 | 628 |
| 15 | N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer Étienne Dardenne et al. · Cancer Cell | Oct 2016 | 586 |
| 16 | Deep learning-based classification of mesothelioma improves prediction of patient outcome Pierre Courtiol, Charles Maussion, Matahi Moarii et al. · Nature Medicine | Oct 2019 | 574 |
| 17 | The hallmarks of cancer immune evasion Claudia Galassi, Timothy An-thy Chan, Ilio Vitale et al. · Cancer Cell | 10 Oct 2024 | 559 |
| 18 | Meta-hallmarks of aging and cancer Carlos López-Otı́n, Federico Pietrocola, David Roiz‐Valle et al. · Cell Metabolism | 2023 | 544 |
| 19 | Targeting immunogenic cell stress and death for cancer therapy Lorenzo Galluzzi, Emma Guilbaud, Darby R. Schmidt et al. · Nature Reviews Drug Discovery | 15 Apr 2024 | 527 |
| 20 | Role of non-coding sequence variants in cancer Ekta Khurana, Yao Fu, Dimple Chakravarty et al. · Nature Reviews Genetics | 19 Jan 2016 | 517 |
| 21 | SvABA: genome-wide detection of structural variants and indels by local assembly Jeremiah A. Wala, Pratiti Bandopadhayay, Noah F. Greenwald et al. · Genome Research | 13 Mar 2018 | 494 |
| 22 | Deep learning enables robust assessment and selection of human blastocysts after in vitro fertilization Pegah Khosravi, Ehsan Mohamad Kazemi, Qiansheng Zhan et al. · npj Digital Medicine | 4 Apr 2019 | 475 |
| 23 | Plasma AR and abiraterone-resistant prostate cancer Alessandro Romanel et al. · Science Translational Medicine | 4 Nov 2015 | 444 |
| 24 | Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer Cora Nanette Sternberg, Karim S. Fizazi, Fred Saad et al. · New England Journal of Medicine | 29 May 2020 | 435 |
| 25 | The spatial landscape of lung pathology during COVID-19 progression André F. Rendeiro, Hiranmayi Ravichandran, Yaron Bram et al. · Nature | 29 Mar 2021 | 409 |
| 26 | Calreticulin and cancer Jitka Palich Fucikova, Radek Špíšek, Guido Kroemer et al. · Cell Research | 30 Jul 2020 | 405 |
| 27 | Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 Silke Gillessen et al. · European Urology | 27 Jan 2020 | 400 |
| 28 | Single-Cell Analysis of the Muscle Stem Cell Hierarchy Identifies Heterotypic Communication Signals Involved in Skeletal Muscle Regeneration Andrea Joseph De Micheli, Emily J. Laurilliard, Charles Lowell Heinke et al. · Cell Reports | Mar 2020 | 392 |
| 29 | Immunological impact of cell death signaling driven by radiation on the tumor microenvironment Maria Esperanza Rodriguez-Ruiz, Ilio Vitale, Kevin Joseph Harrington et al. · Nature Immunology | 23 Dec 2019 | 389 |
| 30 | Clinical features of neuroendocrine prostate cancer Vincenza Conteduca, Clara Oromendia, Kenneth Eng et al. · European Journal of Cancer | 13 Sep 2019 | 381 |
| 31 | Apoptotic cell death in disease—Current understanding of the NCCD 2023 Ilio Vitale et al. · Cell Death and Differentiation | 26 Apr 2023 | 376 |
| 32 | Emerging evidence for adapting radiotherapy to immunotherapy Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman et al. · Nature Reviews Clinical Oncology | 6 Jun 2023 | 374 |
| 33 | Patient derived organoids to model rare prostate cancer phenotypes Loredana Puca et al. · Nature Communications | 13 Jun 2018 | 370 |
| 34 | Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy Takahiro Yamazaki, Alexander Kirchmair, Ai Sato et al. · Nature Immunology | 3 Aug 2020 | 355 |
| 35 | Deep Convolutional Neural Networks Enable Discrimination of Heterogeneous Digital Pathology Images Pegah Khosravi, Ehsan Mohamad Kazemi, Marcin B. Imielinski et al. · EBioMedicine | 28 Dec 2017 | 340 |
| 36 | The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice Alida S. D. Kindt, Gerhard Liebisch, Thomas Clavel et al. · Nature Communications | 10 Sep 2018 | 322 |
| 37 | A Data-Driven Approach to Predicting Successes and Failures of Clinical Trials Kaitlyn M. Gayvert, Neel S. Madhukar, Olivier Elemento · Cell chemical biology | 15 Sep 2016 | 320 |
| 38 | Cancer cell metabolism and antitumour immunity Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi et al. · Nature reviews. Immunology | 22 Apr 2024 | 316 |
| 39 | Clonal evolution of chemotherapy-resistant urothelial carcinoma Bishoy M. Faltas, Davide Prandi, Scott T. Tagawa et al. · Nature Genetics | 17 Oct 2016 | 313 |
| 40 | Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis Jun Li et al. · Cancer Discovery | 28 Dec 2020 | 301 |
| 41 | The role of dendritic cells in cancer and anti-tumor immunity Ariel E. E. Marciscano, Niroshana Anandasabapathy · Seminars in Immunology | Feb 2021 | 300 |
| 42 | Epigenetic memory of coronavirus infection in innate immune cells and their progenitors Jin‐Gyu Cheong et al. · Cell | Aug 2023 | 295 |
| 43 | A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers Himisha Beltran et al. · Clinical Cancer Research | 19 Sep 2018 | 295 |
| 44 | Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs Kevin Hadi et al. · Cell | Oct 2020 | 290 |
| 45 | Trial watch: STING agonists in cancer therapy Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi et al. · OncoImmunology | 2020 | 289 |
| 46 | A guideline on the molecular ecosystem regulating ferroptosis Enyong Dai et al. · Nature Cell Biology | 29 Feb 2024 | 282 |
| 47 | Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system Claire Lhuillier, Nils-Petter Rudqvist, Olivier Elemento et al. · Genome Medicine | 20 Jun 2019 | 280 |
| 48 | Two distinct immunopathological profiles in autopsy lungs of COVID-19 Ronny Nienhold, Yari Ciani, Viktor Hendrik Koelzer et al. · Nature Communications | 8 Oct 2020 | 275 |
| 49 | Single-cell RNA sequencing reveals a signature of sexual commitment in malaria parasites Asaf Poran, Christopher Nötzel, Omar Aly et al. · Nature | 22 Sep 2017 | 274 |
| 50 | A Bayesian machine learning approach for drug target identification using diverse data types Neel S. Madhukar, Prashant K. Khade, Linda S. Huang et al. · Nature Communications | 19 Nov 2019 | 270 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.